589 related articles for article (PubMed ID: 12750821)
1. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
2. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE; Zoghbi HY
Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
[TBL] [Abstract][Full Text] [Related]
3. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 mutations in children with and without the phenotype of Rett syndrome.
Hoffbuhr K; Devaney JM; LaFleur B; Sirianni N; Scacheri C; Giron J; Schuette J; Innis J; Marino M; Philippart M; Narayanan V; Umansky R; Kronn D; Hoffman EP; Naidu S
Neurology; 2001 Jun; 56(11):1486-95. PubMed ID: 11402105
[TBL] [Abstract][Full Text] [Related]
5. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.
Van den Veyver IB; Zoghbi HY
Brain Dev; 2001 Dec; 23 Suppl 1():S147-51. PubMed ID: 11738862
[TBL] [Abstract][Full Text] [Related]
7. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.
Wan M; Lee SS; Zhang X; Houwink-Manville I; Song HR; Amir RE; Budden S; Naidu S; Pereira JL; Lo IF; Zoghbi HY; Schanen NC; Francke U
Am J Hum Genet; 1999 Dec; 65(6):1520-9. PubMed ID: 10577905
[TBL] [Abstract][Full Text] [Related]
8. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.
Young JI; Zoghbi HY
Am J Hum Genet; 2004 Mar; 74(3):511-20. PubMed ID: 14973779
[TBL] [Abstract][Full Text] [Related]
9. [Epigenetic study of Rett's syndrome as an adequate model for autistic disorders].
Iurov IIu; Vorsanova SG; Voinova-Ulas VIu; Villard L; Demidova IA; Giunti L; Guivabyccu-Uzielli ML; Budilov AV; Beresheva AK; Novikov PV; Iurov IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):4-11. PubMed ID: 16117140
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome.
Hammer S; Dorrani N; Dragich J; Kudo S; Schanen C
Ment Retard Dev Disabil Res Rev; 2002; 8(2):94-8. PubMed ID: 12112734
[TBL] [Abstract][Full Text] [Related]
11. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
12. Classic Rett syndrome in a boy with R133C mutation of MECP2.
Masuyama T; Matsuo M; Jing JJ; Tabara Y; Kitsuki K; Yamagata H; Kan Y; Miki T; Ishii K; Kondo I
Brain Dev; 2005 Sep; 27(6):439-42. PubMed ID: 16122633
[TBL] [Abstract][Full Text] [Related]
13. The role of X-chromosome inactivation in the manifestation of Rett syndrome.
Takagi N
Brain Dev; 2001 Dec; 23 Suppl 1():S182-5. PubMed ID: 11738869
[TBL] [Abstract][Full Text] [Related]
14. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype.
Weaving LS; Williamson SL; Bennetts B; Davis M; Ellaway CJ; Leonard H; Thong MK; Delatycki M; Thompson EM; Laing N; Christodoulou J
Am J Med Genet A; 2003 Apr; 118A(2):103-14. PubMed ID: 12655490
[TBL] [Abstract][Full Text] [Related]
15. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
16. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.
Weaving LS; Christodoulou J; Williamson SL; Friend KL; McKenzie OL; Archer H; Evans J; Clarke A; Pelka GJ; Tam PP; Watson C; Lahooti H; Ellaway CJ; Bennetts B; Leonard H; Gécz J
Am J Hum Genet; 2004 Dec; 75(6):1079-93. PubMed ID: 15492925
[TBL] [Abstract][Full Text] [Related]
17. [Genotype-phenotype correlations in Rett syndrome: the study of Russian cohort of patients].
Vorsanova SG; Ulas VIu; Iurov IuB; Giovanucci-Uzielli ML; Demidova IA; Gianti L; Villard L; Iurov IIu; Beresheva AK; Novikov PV
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(10):23-9. PubMed ID: 12449561
[TBL] [Abstract][Full Text] [Related]
18. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
Shahbazian MD; Zoghbi HY
Curr Opin Neurol; 2001 Apr; 14(2):171-6. PubMed ID: 11262731
[TBL] [Abstract][Full Text] [Related]
20. MECP2 mutations account for most cases of typical forms of Rett syndrome.
Bienvenu T; Carrié A; de Roux N; Vinet MC; Jonveaux P; Couvert P; Villard L; Arzimanoglou A; Beldjord C; Fontes M; Tardieu M; Chelly J
Hum Mol Genet; 2000 May; 9(9):1377-84. PubMed ID: 10814719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
